GC Analysis, Anticancer, and Antibacterial Activities of Secondary Bioactive Compounds from Endosymbiotic Bacteria of Pomegranate Aphid and Its Predator and Protector.

Taghreed Alsufyani, Najwa Al-Otaibi, Noura J Alotaibi, Nour Houda M'sakni, Eman M Alghamdi
Author Information
  1. Taghreed Alsufyani: Department of Chemistry, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia. ORCID
  2. Najwa Al-Otaibi: High Altitude Research Centre, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia. ORCID
  3. Noura J Alotaibi: High Altitude Research Centre, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia. ORCID
  4. Nour Houda M'sakni: Department of Chemistry, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia. ORCID
  5. Eman M Alghamdi: Chemistry Department, Faculty of Science, King Abdul Aziz University, P.O. Box 80200, Jeddah 21589, Saudi Arabia. ORCID

Abstract

Bacterial secondary metabolites are a valuable source of various molecules that have antibacterial and anticancer activity. In this study, ten endosymbiotic bacteria of aphids, aphid predators and ants were isolated. Bacterial strains were identified according to the 16S rRNA gene. Ethyl acetate fractions of methanol extract (EA-ME) were prepared from each isolated bacterium and tested for their antibacterial activities using the disk diffusion method. The EA-ME of three bacterial species, sp., , , from the pomegranate aphids , , and , respectively, exhibited elevated antibacterial activity against one or several of the five pathogenic bacteria tested. The inhibition zones ranged from 10.00 ± 0.13 to 20.00 ± 1.11 mm, with minimum inhibitory concentration (MIC) values ranging from 0.156 mg/mL to 1.25 mg/mL. The most notable antibacterial activity was found in the EA-ME of against and , with an MIC value of 0.156 mg/mL. The cytotoxic activity of EA-ME was dependent on the cell line tested. The most significant cytotoxicity effect was observed for extracts of and , at 12.5 µg/mL, against the epithelial cells of lung carcinoma (A549), with a cell reduction of 79.4% and 67.2%, respectively. For the EA-ME of and at 12.5 µg/mL, 69.4% and 67.8% cell reduction were observed against human colon cancer (Hct116), respectively. Gas chromatography-mass spectrometry (GC-MS) analysis of three EA-ME revealed the presence of several bioactive secondary metabolites that have been reported previously to possess antibacterial and anticancer properties. To the best of our knowledge, this is the first study to examine the biological activities of endosymbiotic bacteria in aphids, aphid predators and ants. The promising data presented in this study may pave the way for alternative drugs to overcome the continued emergence of multidrug-resistant bacteria, and find alternative drugs to conventional cancer therapies.

Keywords

References

  1. Org Med Chem Lett. 2013 Aug 28;3(1):9 [PMID: 23981685]
  2. Front Microbiol. 2022 Oct 25;13:961349 [PMID: 36386662]
  3. FEMS Microbiol Lett. 2002 Dec 17;217(2):199-205 [PMID: 12480104]
  4. Saudi J Biol Sci. 2021 Apr;28(4):2613-2617 [PMID: 33911972]
  5. Nature. 2000 Sep 7;407(6800):81-6 [PMID: 10993077]
  6. Proc Biol Sci. 2003 Dec 22;270(1533):2543-50 [PMID: 14728775]
  7. AIMS Microbiol. 2017 Jul 14;3(3):596-612 [PMID: 31294178]
  8. Genes (Basel). 2021 Dec 09;12(12): [PMID: 34946915]
  9. Mol Ecol. 2006 Apr;15(5):1251-61 [PMID: 16626452]
  10. PLoS One. 2011;6(7):e21831 [PMID: 21818272]
  11. Molecules. 2023 Jan 07;28(2): [PMID: 36677687]
  12. Biology (Basel). 2022 Dec 16;11(12): [PMID: 36552343]
  13. Diagn Microbiol Infect Dis. 2004 Nov;50(3):201-4 [PMID: 15541606]
  14. J Antibiot (Tokyo). 2005 Jan;58(1):1-26 [PMID: 15813176]
  15. J Nat Prod. 2016 Mar 25;79(3):629-61 [PMID: 26852623]
  16. Asian Pac J Trop Med. 2014 Sep;7S1:S442-7 [PMID: 25312165]
  17. Mar Drugs. 2019 Aug 23;17(9): [PMID: 31443597]
  18. Curr Opin Biotechnol. 2014 Jun;27:30-7 [PMID: 24863894]
  19. Arch Microbiol. 2021 Oct;203(8):4755-4776 [PMID: 34370077]
  20. Oncol Lett. 2013 Jun;5(6):1787-1792 [PMID: 23833642]
  21. Saudi J Biol Sci. 2017 Feb;24(2):399-404 [PMID: 28149179]
  22. Bull Entomol Res. 2023 Apr;113(2):162-168 [PMID: 36082696]
  23. Anticancer Agents Med Chem. 2019;19(9):1150-1160 [PMID: 30848213]
  24. Iran J Microbiol. 2021 Dec;13(6):839-847 [PMID: 35222863]
  25. Iran J Microbiol. 2021 Aug;13(4):537-543 [PMID: 34557283]
  26. Int J Environ Res Public Health. 2019 Feb 19;16(4): [PMID: 30791418]
  27. CA Cancer J Clin. 2020 Jan;70(1):7-30 [PMID: 31912902]
  28. Front Cell Dev Biol. 2021 Feb 05;9:629182 [PMID: 33614661]
  29. Front Microbiol. 2019 Jun 07;10:1269 [PMID: 31231348]
  30. Toxins (Basel). 2022 Jan 14;14(1): [PMID: 35051034]
  31. Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12795-800 [PMID: 16120675]
  32. Int J Mol Sci. 2022 May 18;23(10): [PMID: 35628466]
  33. Microb Biotechnol. 2011 Nov;4(6):687-99 [PMID: 21375717]
  34. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1803-7 [PMID: 12563031]
  35. Mar Biotechnol (NY). 2005 May-Jun;7(3):245-52 [PMID: 15776311]
  36. Front Microbiol. 2016 Sep 29;7:1538 [PMID: 27746767]
  37. Pharmacogn Rev. 2013 Jan;7(13):11-6 [PMID: 23922451]
  38. Molecules. 2018 Jan 12;23(1): [PMID: 29329257]
  39. Ecancermedicalscience. 2019;13:961 [PMID: 31537986]
  40. EXCLI J. 2017 Mar 24;16:375-387 [PMID: 28507481]
  41. Ecology. 2016 Jul;97(7):1712-1723 [PMID: 27859175]
  42. Microb Cell Fact. 2023 Apr 27;22(1):82 [PMID: 37101185]
  43. Int J Androl. 2006 Feb;29(1):155-65; discussion 181-5 [PMID: 16466535]
  44. J Pharmacol Pharmacother. 2012 Jan;3(1):20-5 [PMID: 22368412]
  45. Antibiotics (Basel). 2021 Nov 28;10(12): [PMID: 34943678]
  46. FEMS Microbiol Lett. 2008 Mar;280(2):250-4 [PMID: 18248425]
  47. Int J Microbiol. 2020 Dec 10;2020:8839490 [PMID: 33488726]
  48. Curr Med Sci. 2021 Aug;41(4):832-840 [PMID: 34403110]
  49. Microbiol Res. 2019 Dec;229:126329 [PMID: 31518853]
  50. Toxins (Basel). 2021 Jul 16;13(7): [PMID: 34357967]
  51. Front Microbiol. 2022 Jul 05;13:870821 [PMID: 35865925]
  52. Nutr Hosp. 2012 Nov-Dec;27(6):1860-5 [PMID: 23588432]
  53. FEMS Microbiol Ecol. 2007 May;60(2):229-39 [PMID: 17313660]
  54. Adv Pharm Bull. 2018 Aug;8(3):507-516 [PMID: 30276148]
  55. Appl Environ Microbiol. 2012 Aug;78(16):5565-74 [PMID: 22660706]
  56. Annu Rev Entomol. 2010;55:247-66 [PMID: 19728837]
  57. Front Endocrinol (Lausanne). 2020 Jun 12;11:295 [PMID: 32595597]
  58. Proc Biol Sci. 2006 Mar 7;273(1586):603-10 [PMID: 16537132]
  59. Front Pharmacol. 2018 Mar 22;9:245 [PMID: 29623040]
  60. Microbes Environ. 2019 Jun 27;34(2):155-160 [PMID: 30905896]
  61. Avicenna J Med Biotechnol. 2020 Jan-Mar;12(1):61-65 [PMID: 32153740]
  62. Nutrients. 2020 Jun 03;12(6): [PMID: 32503225]
  63. Sci Rep. 2019 Jul 29;9(1):10941 [PMID: 31358890]
  64. Plant Signal Behav. 2011 Dec;6(12):2008-12 [PMID: 22105034]
  65. Sci Rep. 2019 Apr 8;9(1):5766 [PMID: 30962510]
  66. Int J Mol Sci. 2018 Dec 24;20(1): [PMID: 30586850]
  67. Front Nutr. 2023 Mar 01;10:1133342 [PMID: 36937358]
  68. Int J Microbiol. 2021 Apr 12;2021:8812043 [PMID: 33953751]
  69. Science. 2005 Dec 16;310(5755):1781 [PMID: 16357252]
  70. Mol Mar Biol Biotechnol. 1994 Oct;3(5):294-9 [PMID: 7881515]
  71. Methods Mol Biol. 2022;2343:215-228 [PMID: 34473325]
  72. Insects. 2018 Nov 10;9(4): [PMID: 30423824]
  73. Prog Lipid Res. 2021 Apr;82:101093 [PMID: 33577909]
  74. Int J Mol Cell Med. 2014 Fall;3(4):246-54 [PMID: 25635251]
  75. Molecules. 2019 Jan 31;24(3): [PMID: 30708936]
  76. Mar Drugs. 2017 Jan 10;15(1): [PMID: 28075408]
  77. World J Microbiol Biotechnol. 2012 Feb;28(2):761-6 [PMID: 22806873]
  78. Exp Anim. 2017 Aug 5;66(3):283-291 [PMID: 28450692]
  79. Antibiot Annu. 1956-1957;:892-7 [PMID: 13425478]
  80. Insects. 2017 Mar 28;8(2): [PMID: 28350349]
  81. Mycobiology. 2009 Mar;37(1):31-6 [PMID: 23983504]
  82. Int J Mol Sci. 2020 Jul 31;21(15): [PMID: 32752126]
  83. Microbiologyopen. 2019 Dec;8(12):e914 [PMID: 31420951]
  84. Saudi J Biol Sci. 2019 Mar;26(3):600-604 [PMID: 30899178]

Grants

  1. 1/441/119/Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia,

MeSH Term

Animals
Humans
Aphids
Pomegranate
Plant Extracts
RNA, Ribosomal, 16S
Anti-Bacterial Agents
Bacteria
Microbial Sensitivity Tests

Chemicals

Plant Extracts
RNA, Ribosomal, 16S
Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0antibacterialEA-MEbacteriaactivityactivitiessecondaryanticancerstudyendosymbioticaphidstestedrespectively0mg/mLcellBacterialmetabolitesaphidpredatorsantsisolatedthreeseveral00±1MIC156observed125µg/mLreduction4%67cancerGC-MSbioactivealternativedrugsvaluablesourcevariousmoleculestenstrainsidentifiedaccording16SrRNAgeneEthylacetatefractionsmethanolextractpreparedbacteriumusingdiskdiffusionmethodbacterialspeciessppomegranateexhibitedelevatedonefivepathogenicinhibitionzonesranged10132011mmminimuminhibitoryconcentrationvaluesranging25notablefoundvaluecytotoxicdependentlinesignificantcytotoxicityeffectextractsepithelialcellslungcarcinomaA549792%698%humancolonHct116Gaschromatography-massspectrometryanalysisrevealedpresencereportedpreviouslypossesspropertiesbestknowledgefirstexaminebiologicalpromisingdatapresentedmaypavewayovercomecontinuedemergencemultidrug-resistantfindconventionaltherapiesGCAnalysisAnticancerAntibacterialActivitiesSecondaryBioactiveCompoundsEndosymbioticBacteriaPomegranateAphidPredatorProtectorAphispunicaeTaif-pomegranatepredatorprotector

Similar Articles

Cited By